Kemptamide

CAS No. 89315-28-6

Kemptamide( ——— )

Catalog No. M42205 CAS No. 89315-28-6

Kemptamide, a 13 amino acid fragment with a sequence corresponding to residues 11-23 of gizzard light chain. Kemptamide is a peptide substrate of myosin light-chain kinase (MLCK).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Kemptamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Kemptamide, a 13 amino acid fragment with a sequence corresponding to residues 11-23 of gizzard light chain. Kemptamide is a peptide substrate of myosin light-chain kinase (MLCK).
  • Description
    Kemptamide is a synthetic peptide with 13-residue.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    89315-28-6
  • Formula Weight
    1517.76
  • Molecular Formula
    C65H112N24018
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. C Foster, et al. Tryptic digestion of myosin light chain kinase produces an inactive fragment that is activated on continued digestion. Arch Biochem Biophys. 1986 Dec;251(2):616-23.?
molnova catalog
related products
  • L-Argininamide dihyd...

    L-Argininamide (L-Arm) is used as a model compound in studies of the physicochemical characteristic of ligand binding DNA aptamers and their potential development as fluorescent aptasensors.

  • Cancer-Targeting Com...

    Cancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among others.

  • PZM21

    PZM21 is an effective and selective μ opioid receptor agonist (EC50: 1.8 nM).